Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-05-22 14:17:31 UTC |
---|
Updated at | 2021-06-29 00:47:18 UTC |
---|
NP-MRD ID | NP0000370 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 5-Methoxydimethyltryptamine |
---|
Description | 5-Methoxydimethyltryptamine, like all methoxydimethyltryptamines is a compound that contain the biogenic monoamine tryptamine and is substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia. They are formed as metabolites of serotonin (5-hydroxytryptamine) or tryptamine by the enzyme indolethylamine N-methyltransferase (INMT). The physiological significance of the N-methylating pathway of indoleamine metabolism, and of the methylated end products, is unknown. Because of the known psychotropic properties of the dimethylated amines, their possible involvement in the chemical pathogenesis of mental disorders has received wide interest. The hallucinogenic actions of the methylated indoleamines, like those of LSD, are believed to be mediated through the 5HT2 receptor. (PMID 11763413 ). |
---|
Structure | COC1=CC2=C(NC=C2CCN(C)C)C=C1 InChI=1S/C13H18N2O/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3 |
---|
Synonyms | Value | Source |
---|
3-(2-Dimethylaminoethyl)-5-methoxyindole | ChEBI | 3-[2-(N,N-Dimethylamino)ethyl]-5-methoxy-indole | ChEBI | 5-MeO-DMT | ChEBI | 5-Methoxy-N,N-dimethyl-1H-indole-3-ethanamine | ChEBI | MeODMT | ChEBI | Methoxybufotenin | ChEBI | N,N-Dimethyl-5-methoxytryptamine | ChEBI | O-Methylbufotenine | ChEBI | 5-Methoxy-N,N-dimethyltryptamine | Kegg | 3-(2-(N,N-Dimethyl)aminoethyl)-5-methoxyindole | HMDB | 5-Methoxy-N,N-dimethyl-1H-indole-3-ethylamine | HMDB | 5-Methoxyindole 3-(2-(N,N-dimethylamino)ethyl) | HMDB | Bufotenine, 5-methoxydimethyltryptamine | HMDB | Methylbufotenine | HMDB | N,N-Dimethyl-5-methoxy tryptamine | HMDB | Methoxydimethyltryptamines | HMDB | Methoxydimethyltryptamine | HMDB | Methylbufotenin | HMDB | 5 Methoxy N,N dimethyltryptamine | HMDB | N,N Dimethyl 5 methoxytryptamine | HMDB |
|
---|
Chemical Formula | C13H18N2O |
---|
Average Mass | 218.2948 Da |
---|
Monoisotopic Mass | 218.14191 Da |
---|
IUPAC Name | [2-(5-methoxy-1H-indol-3-yl)ethyl]dimethylamine |
---|
Traditional Name | 5-MeO-DMT |
---|
CAS Registry Number | 1019-45-0 |
---|
SMILES | COC1=CC2=C(NC=C2CCN(C)C)C=C1 |
---|
InChI Identifier | InChI=1S/C13H18N2O/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3 |
---|
InChI Key | ZSTKHSQDNIGFLM-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, simulated) | varshavi.d26@gmail.com | Not Available | Not Available | 2021-08-09 | View Spectrum |
| Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tryptamines and derivatives. Tryptamines and derivatives are compounds containing the tryptamine backbone, which is structurally characterized by an indole ring substituted at the 3-position by an ethanamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Tryptamines and derivatives |
---|
Direct Parent | Tryptamines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Tryptamine
- 3-alkylindole
- Indole
- Alkaloid or derivatives
- Anisole
- Alkyl aryl ether
- Aralkylamine
- Benzenoid
- Substituted pyrrole
- Heteroaromatic compound
- Pyrrole
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Ether
- Organooxygen compound
- Organonitrogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Uebelhack R, Franke L, Seidel K: [Methylated and unmethylated indolamine in the cisternal fluid in acute endogenous psychoses]. Biomed Biochim Acta. 1983;42(10):1343-6. [PubMed:6144308 ]
- Forsstrom T, Tuominen J, Karkkainen J: Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS. Scand J Clin Lab Invest. 2001;61(7):547-56. [PubMed:11763413 ]
- Riga MS, Soria G, Tudela R, Artigas F, Celada P: The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. Int J Neuropsychopharmacol. 2014 Aug;17(8):1269-82. doi: 10.1017/S1461145714000261. Epub 2014 Mar 20. [PubMed:24650558 ]
- Jiang XL, Shen HW, Yu AM: Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors. Neuropharmacology. 2015 Feb;89:342-51. doi: 10.1016/j.neuropharm.2014.10.013. [PubMed:25446678 ]
- Duvvuri V, Risbrough VB, Kaye WH, Geyer MA: 5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition. Pharmacol Biochem Behav. 2009 Sep;93(3):349-53. doi: 10.1016/j.pbb.2009.05.014. Epub 2009 May 31. [PubMed:19490926 ]
- Riga MS, Bortolozzi A, Campa L, Artigas F, Celada P: The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors. Neuropharmacology. 2016 Feb;101:370-8. doi: 10.1016/j.neuropharm.2015.10.016. Epub 2015 Oct 23. [PubMed:26477571 ]
- Dakic V, Minardi Nascimento J, Costa Sartore R, Maciel RM, de Araujo DB, Ribeiro S, Martins-de-Souza D, Rehen SK: Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Sci Rep. 2017 Oct 9;7(1):12863. doi: 10.1038/s41598-017-12779-5. [PubMed:28993683 ]
|
---|